Differential expression of angiotensin-converting enzyme and chymase in dogs with chronic mitral regurgitation

Journal of Molecular and Cellular Cardiology

Volumn 31, Issue 5, 1999, Pages 1033-1045

  Xuefeng, Su ^a   Chih Chang, Wei ^a   Machida, Naburo ^c   Bishop, Sanford P ^a   Hankes, Gerald H ^b   Dillon, A Ray ^b   Oparil, Suzanne ^a   Dell'Italia, Louis J ^a  

^a University of Alabama at Birmingham   (United States)

^b AUBURN UNIVERSITY   (United States)

^c TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

Angiotensin II; Angiotensin converting enzyme; Heart failure; Hypertrophy

Indexed keywords

ANGIOTENSIN; CHYMASE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MESSENGER RNA; RAMIPRIL;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HEART; HEART FAILURE; HEART LEFT VENTRICLE; KIDNEY; LUNG; MITRAL VALVE REGURGITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SPECIFICITY;

EID: 0033136129     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1999.0933     Document Type: Article

References (37)

1. 1 receptor subtype in failing human ventricular myocardium. Circulation 95: 1193-1200.
2. Balcells E, Meng QC, Johnson W, Oparil S, Dell'Italia LJ, 1997. Angiotensin II formation from ACE and chymase in human and animal hearts: Methods and species considerations. Am J Physiol (Heart Circ Physiol 42) 273: H1769-H1774.
3. Burns L, Clark KL, Bradley J, Robertson MJ, Clark AJ, 1994. Molecular cloning of the canine angiotensin II receptor. An AT1-like receptor with reduced affinity for DuP753. FEBS Letters 343: 146-150.
4. Caughey GH, Raymond WW, Vanderslice P, 1990. Dog mast cell chymase: Molecular cloning and characterization. Biochemistry 29(21): 5166-5171.
5. Chomczynski P, Sacchi N, 1987. Single step method of RNA isolation by guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1162: 156-159.
6. Dell'Italia LJ, Meng QC, Balcells E, Straeter-Knowlen IM, Hankes G, Dillon R, Cartee RE, Orr R, Bishop SP, Oparil S, Elton T, 1995. Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation. Am J Physiol (Heart Circ Physiol 38) 269: H2065-H2073.
7. Dell'Italia LJ, Balcells E, Meng QC, Su X, Schultz D, Bishop SP, Machida N, Straeter-Knowlen IM, Hankes GH, Dillon R, Cartee RE, Oparil S, 1997. Volume overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in the dog. Am J Physiol (Heart Circ Physiol 42) 273: H961-H970.
8. Dzau VJ, 1989. Multiple pathways of angiotensin production in the blood vessel wall: Evidence, possibilities and hypotheses. J Hypertension 7: 933-936.
9. Erman A, Winkler J, Chen-Gal B, et al., 1991. Inhibition of angiotensin converting enzyme by ramipril in serum and tissue of man. J Hypertension 9: 1057-1062.
10. FYhrquist F, Hortling L, Gronhagen-Riska C, 1982. Induction of angiotensin I-converting enzyme by captopril in cultured human endothelial cells. J Clin Endocrinol Metab 55: 783-786.
11. 2 angiotensin receptor gene expression in human heart failure. Circulation 95: 1201-1206.
12. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ, 1991. Tissue-specific activation of cardiac angiotensin-converting enzyme in experimental heart failure. Circ Res 69: 475-482.
13. Iwai N, Shimoike H, Kinoshita M, 1995. Cardiac renin-angiotensin system in the hypertrophied heart. Circulation 92:2690-2696.
14. Johnston CI, 1994. Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension 23: 258-268.
15. Keuneke C, Yacullo R, Sugiura M, Mall G, Metzger R, Ganten D, 1995. Converting enzyme inhibitors differentially affect expression of genes of the renin-angiotensin system. Clin Exper Hypertension 17(3): 551-574.
16. King SJ, Oparil S, 1992. Converting-enzyme inhibitors increase converting-enzyme mRNA and activity in endothelial cells. Am J Physiol (Cell Physiol 32) 263: C743-C749.
17. King SJ, Oparil S, Berecek K, 1991. Neuronal angiotensin-converting enzyme (ACE) gene expression is increased by converting enzyme inhibitors. Mol Cell Neurosci 2: 13-20.
18. Lindpaintner K, Ganten D, 1991. The cardiac renin-angiotensin system: An appraisal of present experimental and clinical evidence. Circ Res 68: 905-921.
19. Meng QC, Durand J, Chen Y, Oparil S, 1993. Simplified method for quantification of angiotensin peptides in tissue. J Chromatography 614:19-25.
20. Meng QC, Durand J, Chen Y, Oparil S, 1995. Effects of dietary salt on angiotensin peptides in kidney. J Am Soc Nephrol 6: 1209-1215.
21. Nakamura A, Iwai H, Fukui K, Kimura S, Tamaki T, Nakanish S, Youichi ABE, 1990. Regulation of liver angiotensinogen and kidney renin mRNA levels by angiotensin II. Am J Physiol (Endocrinol Metab 21) 258: E1-E6.
22. Okunishi H, Oka Y, Shiota N, Kawamoto T, Song K, Miyazaki M, 1993. Marked species-difference in the vascular angiotensin II-forming pathways: Humans v rodents. Jpn J Pharmacol 62: 207-210.
23. Pieruzzi F, Abassi ZA, Keiser HR, 1995. Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure. Circulation 92: 3105-3112.
24. Ruzicka M, Skarda V, Leenen FHH, 1995. Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats. Circulation 92: 3568-3573.
25. Sadoshima J, Xu Y, Slayter HS, Izumo S, 1993. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75: 977-984.
26. Samani NJ, Cumin F, Kelly M, Wood JM, 1994. Expression of components of the RAS during prolonged blockade at different levels in primates. Am J Physiol (Endocrinol Metab 30) 267: E612-E619.
27. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH, 1990. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy: Effects on coronary resistance, contractility and relaxation. J Clin Invest 86: 1913-1920.
28. Schunkert H, Ingelfinger JR, Hirsch AT, Tang SS, Litwin SE, Talsness CE, Dzau VJ, 1992. Evidence for tissue-specific activation of the renal angiotensinogen mRNA expression in chronic stable experimental heart failure. J Clin Invest 90: 1523-1529.
29. Schunkert H, Ingelfinger JR, Hirsch AT, Pinto Y, Remme WJ, Jacob H, Dzau VJ, 1993. Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circ Res 72: 312-318.
30. Studer R, Reinecke H, Muller B, Holtz J, Hanjorg J, Drexler H, 1994. Increased angiotensin-I converting enzyme gene expression in the failing human heart. J Clin Invest 94: 301-310.
31. Urata H, Healy B, Stewart RW, Bumpus FM, Husain A, 1990a. Angiotensin II-forming pathways in normal and failing human hearts. Circ Res 66: 883-890.
32. Urata H, Kinoshita A, Misono KS, Bumpus FM, Husain A, 1990b. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 265: 22348-22357.
33. Urata H, Boehm KD, Philip A, Kinoshita A, Gabrovsek J, Bumpus FM, Hussain A, 1993. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest 91: 1269-1281.
34. 1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to aortic stenosis. Circulation 95: 1592-1600.
35. Young-Ae L, Chang-Seng L, Min-Ae L, Lindpaintner K, 1996. Local stress, not systemic factors, regulate gene expression of the cardiac renin-angiotensin system in vivo: A comprehensive study of all its components in the dog. Proc Nat Acad Sci USA 93: 11035-11040.
36. Zisman LS, Abraham WT, Meixell GE, Vamvakias BN, Quaife RA, Lowes BD, Roden RL, Peacock SJ, Groves BM, Raynolds MV, Bristow MR, Ferryman MB, 1995. Angiotensin II formation in the intact human heart. J Clin Invest 95: 1490-1498.
37. 1 receptor density in the failing human heart. Circualtion 98: 1735-1741.